What's Happening?
Invivoscribe has introduced the PrepQuant sample preparation platform, which integrates nucleic acid extraction, concentration, and quantification into a single automated instrument. Developed in collaboration with Hitachi High-Tech Corporation, this
system aims to standardize and streamline pre-analytical workflows in molecular testing. The PrepQuant system is designed to reduce costs, minimize sample variability, and optimize test results by consolidating multiple steps into one platform. It is validated for use with blood, plasma, and bone marrow specimens, with plans to expand to other specimen types.
Why It's Important?
The launch of the PrepQuant system represents a significant advancement in molecular testing, particularly in the era of precision medicine. By standardizing the pre-analytical workflow, the system enhances the reliability of measurable residual disease and liquid biopsy results, which are crucial for accurate diagnosis and treatment planning. This innovation could lead to improved patient outcomes and more efficient laboratory operations, benefiting both healthcare providers and patients. The system's ability to reduce costs and increase consistency is particularly important as healthcare systems strive to deliver high-quality care while managing expenses.
